161 related articles for article (PubMed ID: 19079344)
1. TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation.
Fleming YM; Ferguson GJ; Spender LC; Larsson J; Karlsson S; Ozanne BW; Grosse R; Inman GJ
Oncogene; 2009 Feb; 28(7):983-93. PubMed ID: 19079344
[TBL] [Abstract][Full Text] [Related]
2. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.
Ghosh AK; Wei J; Wu M; Varga J
Biochem Biophys Res Commun; 2008 Sep; 374(2):231-6. PubMed ID: 18627765
[TBL] [Abstract][Full Text] [Related]
3. Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells.
Spender LC; Ferguson GJ; Liu S; Cui C; Girotti MR; Sibbet G; Higgs EB; Shuttleworth MK; Hamilton T; Lorigan P; Weller M; Vincent DF; Sansom OJ; Frame M; Dijke PT; Marais R; Inman GJ
Oncotarget; 2016 Dec; 7(50):81995-82012. PubMed ID: 27835901
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.
Edlund S; Landström M; Heldin CH; Aspenström P
Mol Biol Cell; 2002 Mar; 13(3):902-14. PubMed ID: 11907271
[TBL] [Abstract][Full Text] [Related]
5. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
8. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
[TBL] [Abstract][Full Text] [Related]
10. TGFβ-induced early activation of the small GTPase RhoA is Smad2/3-independent and involves Src and the guanine nucleotide exchange factor Vav2.
Papadimitriou E; Kardassis D; Moustakas A; Stournaras C
Cell Physiol Biochem; 2011; 28(2):229-38. PubMed ID: 21865730
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
Walsh MF; Ampasala DR; Hatfield J; Vander Heide R; Suer S; Rishi AK; Basson MD
Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
[TBL] [Abstract][Full Text] [Related]
12. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition.
DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z
J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393
[TBL] [Abstract][Full Text] [Related]
13. Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes.
Yoon JH; Jung SM; Park SH; Kato M; Yamashita T; Lee IK; Sudo K; Nakae S; Han JS; Kim OH; Oh BC; Sumida T; Kuroda M; Ju JH; Jung KC; Park SH; Kim DK; Mamura M
EMBO Mol Med; 2013 Nov; 5(11):1720-39. PubMed ID: 24127404
[TBL] [Abstract][Full Text] [Related]
14. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
[TBL] [Abstract][Full Text] [Related]
15. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability.
Birukova AA; Adyshev D; Gorshkov B; Birukov KG; Verin AD
FEBS Lett; 2005 Jul; 579(18):4031-7. PubMed ID: 16004987
[TBL] [Abstract][Full Text] [Related]
16. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
Koo BH; Kim Y; Je Cho Y; Kim DS
Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
Vasilaki E; Papadimitriou E; Tajadura V; Ridley AJ; Stournaras C; Kardassis D
FASEB J; 2010 Mar; 24(3):891-905. PubMed ID: 19890017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
